| Roche Pharma (Schweiz) AG - Mircera 360 ug / 0.6 ml, Fertigspritzen |
| 57860 | | 14 | | Mircera 360 ug / 0.6 ml | | Fertigspritzen | | B03XA03 | | Methoxy Polyethylene Glycol-Epoetin Beta | | 10.09.2008 | | |
|
| Composition |
| methoxy polyethylene glycol-epoetinum beta 360 µg, natrii sulfas anhydricus, natrii dihydrogenophosphas monohydricus, mannitolum, poloxamerum 188, antiox.: methioninum, aqua ad iniectabilia q.s. ad solutionem pro 0.6 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Methoxy Polyethylene Glycol-Epoetinum Beta | 360µg / 0.6ml |
| | | | Inactive agents | Dose | additional_information |
|---|
| Mannitol | | | | Methionine | | antiox. | | Sodium Dihydrogenophosphate Monohydrate | | | | Sodium Sulfate Anhydrate | | | | Poloxamer | 188 | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
